TEM-89 β-Lactamase Produced by a Proteus mirabilis Clinical Isolate: New Complex Mutant (CMT 3) with Mutations in both TEM-59 (IRT-17) and TEM-3
2001 ◽
Vol 45
(12)
◽
pp. 3591-3594
◽
Keyword(s):
ABSTRACT TEM-89 (CMT-3) is the first complex mutant β-lactamase produced by a clinical strain of Proteus mirabilis (strain Pm 631). This new enzyme, which has a pI of 6.28, is derived from TEM-3 and has a single amino acid substitution also encountered in TEM-59 (inhibitor-resistant TEM β-lactamase IRT-17): Ser-130 to Gly. TEM-89 hydrolyzed penicillins to the same extent that TEM-3 did but lost almost all hydrolytic activity for cephalosporins and, like TEM-59, was highly resistant to inhibitors.
2009 ◽
Vol 298
(2)
◽
pp. 249-254
◽
Keyword(s):
2012 ◽
Vol 56
(4)
◽
pp. 2184-2186
◽
2000 ◽
Vol 44
(3)
◽
pp. 760-762
◽
2000 ◽
Vol 44
(6)
◽
pp. 1725-1727
◽
Keyword(s):
1994 ◽
Vol 269
(6)
◽
pp. 4450-4457
1990 ◽
Vol 265
(36)
◽
pp. 22520-22525
Keyword(s):